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Use of a proximal anastomotic device in coronary artery bypass
surgery: A word of caution
G. Phillip Schoettle, Jr, MD, Memphis, Tenn
Patients undergoing coronary artery bypass graft surgery(CABG) today are older and have increased comorbidi-ties than those a decade ago.1 In an effort to maintainfavorable morbidity and mortality data, many cardiac
surgeons have begun to perform CABG with less invasive tech-
niques. Avoiding cardiopulmonary bypass and minimizing aortic
manipulation with sutureless aortic connectors are two ways to
potentially achieve this goal.2,3 A review of patients with the
Symmetry aortic connector (St Jude Medical, Inc, Minneapolis,
Minn), however, has shown a high percentage of early graft
occlusions.
Clinical Summary
I report a retrospective review of two patient groups undergoing
CABG. In group A, 323 patients underwent surgery from October
2000 through September 2001. In group B, 305 patients underwent
surgery from October 2001 through September 2002. All opera-
tions were performed by the same surgeon, and 95% of all proce-
dures in both groups were done without cardiopulmonary bypass.
Group A patients had the proximal vein–aorta anastomoses
done in the usual fashion with a partial occlusion clamp on the
aorta and hand-sewn grafts. The patients in group B received
saphenous vein–aorta connections with the St Jude Symmetry
device with no aortic clamping. All patients had operative graft
patency confirmed with the use of the Medistem transit time flow
probe (Medtronic, Inc, Minneapolis, Minn). Patients in both
groups received continuous postoperative aspirin and received
clopidogrel daily for 2 months.
After institutional review board approval was obtained, a cath-
eterization laboratory database was used to determine which pa-
tients had undergone repeat cardiac catheterization after the CABG
procedure. End points of reoperative CABG and death were re-
ported as observed. The decision to perform repeat cardiac cath-
eterization was made by each patient’s cardiologist and most
commonly was based on a clinical suspicion of recurrent ischemia.
To date, 40 patients in group A have undergone repeated
cardiac catheterization, and of 71 venous grafts studied, 61 were
widely patent. Forty-five patients in group B have undergone
repeated cardiac catheterization, and of 88 venous grafts studied,
39 were totally occluded. Seventeen had 90% or greater stenosis,
and 15 had 50% or greater stenosis (Table 1). These stenoses
uniformly occurred at the connector site. Among the patients
studied, this represented an 80% rate of occlusion or stenosis with
the proximal venous graft connectors.
Five patients in group B have required early reoperative
CABG, and 30 patients have required percutaneous transluminal
coronary angioplasty (PTCA) and stenting to relieve the conse-
quences of venous graft occlusion or stenosis. No patients in group
A have required reoperative CABG, and only 6 have had PTCA
and stenting, primarily for ungrafted or ungraftable vessels. Four
patients in group B have had sudden death, all remote from the
original bypass procedure. One patient had documented acute
myocardial infarction 6 months after CABG during salvage fem-
oral-popliteal grafting and was unable to be resuscitated. No pa-
tient in group A is known to have had postoperative sudden death.
Discussion
During the past decade many cardiac surgeons have adopted new
technology in attempts to make CABG less invasive. The Sym-
metry aortic connector is primarily used to minimize trauma to the
aorta from clamping. Potential benefits include a decreased inci-
dence of stroke from aortic embolization and prevention of aortic
dissection from the partial occlusion clamp. Other possible benefits
are a technically superior proximal anastomosis and rapidity of use
with decreased operative time.
After Food and Drug Administration approval in 1998 and
training by St Jude Medical in its use (September 2001) I exclu-
sively incorporated the proximal anastomotic device into my
CABG practice. After 12 months, it was apparent that the inci-
dence of saphenous vein occlusion or stenosis associated with the
proximal connector was not compatible with my previous off-
pump CABG experience. The large number of aortic venous graft
connector stenoses or occlusions seen in group B have required
multiple interventions—either PTCA and stenting, reoperative
CABG, or aggressive medical therapy in patients not amenable to
repeated intervention. The patients in group A, although subjected
to a longer period of observation, have not had an unexpected
number of venous graft occlusions, nor have they required the
large number of interventions needed by those in group B.
The 4 sudden deaths among the patients with connector use and
the documented venous graft occlusions or stenoses leading to
early reoperative CABG are cause for concern. I also note that the
patients who require PTCA and stents to relieve proximal connec-
tor venous graft stenosis are likely subject to the restenosis rate
inherent in stented vessels.
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The proximal connector device is appealing for the reasons
mentioned previously. For facilitated anastomoses to justify the
expense and replace traditional hand-sewn grafts, however, they
must have equal or better short- and long-term patencies. Despite
potential benefits of sutureless aortic connections, this patient
review demonstrates unacceptable saphenous venous graft stenosis
and occlusion with the use of the Symmetry aortic connector.
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Apicoaortic conduit in a patient with severe hemolysis after three
aortic valve replacements
Christian A. Skrabal, MD,a Matthias Loebe, MD, PhD,a Larry O. Thompson, MD,a John M. Buergler, MD,b
Keith A. Youker, PhD,a Javier A. Lafuente, MD,a and George P. Noon, MD,a Houston, Tex
Left ventricular outflow obstruction usually requires re-pair or replacement of the aortic valve or resection of asubannular stenosis. Cooley and Norman1 proposed theimplantation of a valve-containing conduit between the
apex of the left ventricle and the descending thoracic aorta for
treatment of complex outflow obstruction. Following a 5-year
follow-up, we report the case of a patient who underwent apicoaor-
tic conduit implantation in 1997.
Clinical Summary
The patient had a history of 3 previous aortic valve replacements
including replacement of the ascending aorta for repair of pros-
thetic endocarditis with annular abscess. The need for the implan-
tation of an apicoaortic conduit arose from an enduring hemolysis
secondary to a relatively undersized aortic valve prosthesis. In
1975, the then 36-year-old man underwent replacement of a bi-
cuspid stenotic aortic valve with a Bjo¨rk-Shiley convexo-concave
(BSCC) mechanical heart valve (Shiley, Inc, Irvine, Calif, a sub-
sidiary of Pfizer, Inc). In September 1995, the patient had a high
fever, chills, fatigue, joint pain, and painful peripheral subcutane-
ous nodes of the phalanges. Echocardiography revealed a paraval-
vular leak with fistula to the right ventricle. Blood cultures were
positive for Staphylococcus aureus. After prolonged intravenous
antibiotic therapy, replacement of the Bjo¨rk-Shiley valve and
repair of the aortaright ventricular fistula was performed by
implantation of a 21-mm St Jude Medical valve (St Jude Medical,
St Paul, Minn) with aortic root replacement using a Hemashield
graft (Meadox Medicals, Inc, Oakland, NJ). The coronary arteries
were reinserted by the Cabrol technique. In October 1996, how-
ever, the patient had increasing fatigue, and echocardiography
showed severe subvalvular aortic stenosis. The aortic valve area
was 0.6 cm2 with a mean pressure gradient of 56 mm Hg and a
peak velocity of the stenotic jet of 4.85 m/s. An attempt was made
to excise the stenosis through the valve but the valve broke under
the stress. After resection of the valve and subvalvular stenosis, a
19-mm St Jude Medical prosthesis was implanted. Subsequently,
the patient began to experience hemolysis with consecutive anemia
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TABLE 1. Comparison of results between patients with
(group B) and without (group A) connectors
Group A
(n  323)
Group B
(n  305) P value
Patients undergoing repeated
cardiac catheterization
40 45 NS
Venous grafts studied 71 88 NS
Venous grafts patent 61 18 .0001
Venous grafts occluded 10 39 .0001
Venous grafts with 50%
stenosis
0 31 .0001
NS, Not significant.
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